Hyejeong Jang Selected Research

Copper

1/2019

Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyejeong Jang Research Topics

Disease

9	Neoplasms (Cancer) 12/2023 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2019 - 01/2018
2	Pleural Effusion (Pleural Effusions) 01/2017 - 01/2016
1	Endometrioid Carcinoma 02/2024
1	Microsatellite Instability 05/2023
1	Turcot syndrome 05/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Disease Progression 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Inflammation (Inflammations) 01/2023
1	Lymphatic Metastasis 11/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Esophagitis 01/2022
1	Dermatitis 01/2022
1	Morbid Obesity 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022
1	7 Hereditary Prostate Cancer 09/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Pneumonia (Pneumonitis) 02/2019
1	Acute Kidney Injury (Acute Renal Failure) 02/2019
1	Tics (Tic) 01/2019
1	Wounds and Injuries (Trauma) 09/2017
1	Fever (Fevers) 01/2017
1	Cognitive Dysfunction 03/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2014

Drug/Important Bio-Agent (IBA)

2	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 01/2020
2	PlatinumIBA 10/2022 - 01/2020
1	Epidermal Growth Factor (EGF)IBA 02/2024
1	ProteomeIBA 12/2023
1	ChromograninsIBA 05/2023
1	SynaptophysinIBA 05/2023
1	Phosphatidylethanolamines (Cephalins)IBA 01/2023
1	LipidsIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Hematoxylin (Haematoxylon)IBA 11/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2022
1	human ERBB2 proteinIBA 01/2022
1	Brentuximab VedotinIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Fatty Acid DesaturasesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	CollagenIBA 09/2021
1	Discoidin Domain Receptor 1IBA 09/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2021
1	Ubiquitin-Specific ProteasesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 02/2019
1	Disulfiram (Antabuse)FDA Link 01/2019
1	CopperIBA 01/2019
1	NVP-BKM120IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2018
1	thymoglobulin FDA Link 01/2018
1	FluoroquinolonesIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	SmokeIBA 03/2014

Therapy/Procedure

3	Therapeutics 11/2020 - 02/2019
3	Hematopoietic Stem Cell Transplantation 10/2019 - 01/2016
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2019
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Radiotherapy 01/2022
1	Chemoradiotherapy 11/2020
1	Liver Transplantation 10/2019
1	Nephrectomy 02/2019
1	Cell Transplantation 01/2018
1	Mechanical Ventilators (Ventilator) 09/2017